Unlike genetic mutations, DNA methylation is a reversible process. This opens up possibilities for therapeutic interventions. For instance, epigenetic drugs like DNA methyltransferase inhibitors are being investigated for their potential to correct abnormal methylation patterns and treat certain neonatal disorders.
